Efficacy News and Research

RSS
Deep brain stimulation helps improve memory in patients with psychiatric illness

Deep brain stimulation helps improve memory in patients with psychiatric illness

Peregrine's selective anti-VEGF antibodies shown to be as effective as Avastin

Peregrine's selective anti-VEGF antibodies shown to be as effective as Avastin

Potential treatments for mouth ulcers

Potential treatments for mouth ulcers

New tumor antigen found with new cloning technique

New tumor antigen found with new cloning technique

New chemical agent, MCP110, provides synergistic effect to standard drugs

New chemical agent, MCP110, provides synergistic effect to standard drugs

Chaetocin shows promise as a new anti-myeloma agent

Chaetocin shows promise as a new anti-myeloma agent

Human Genome Sciences reports results of phase 2b trial of Albuferon

Human Genome Sciences reports results of phase 2b trial of Albuferon

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program

Essential medicines for children

Essential medicines for children

GlaxoSmithKline initiates study of PROMACTA in chronic idiopathic thrombocytopenic purpura

GlaxoSmithKline initiates study of PROMACTA in chronic idiopathic thrombocytopenic purpura

Gleevec decreases cancer recurrence for GIST

Gleevec decreases cancer recurrence for GIST

Genmab starts HuMax-EGFr combination study

Genmab starts HuMax-EGFr combination study

Cytokinetics initiates of phase II clinical trial for CK-1827452

Cytokinetics initiates of phase II clinical trial for CK-1827452

Coley Pharmaceutical licenses VaxImmune to Merck

Coley Pharmaceutical licenses VaxImmune to Merck

FDA approves GlaxoSmithKline's antibacterial Altabax

FDA approves GlaxoSmithKline's antibacterial Altabax

New vaccine to prevent type-1 polio three times as effective as standard vaccine

New vaccine to prevent type-1 polio three times as effective as standard vaccine

Oncolytics Biotech to proceed with phase II Sarcoma trial

Oncolytics Biotech to proceed with phase II Sarcoma trial

OHSU surgeon implants donated tissue allografts

OHSU surgeon implants donated tissue allografts

Novalar Pharmaceuticals submits NDA for dental anesthetic reversal agent

Novalar Pharmaceuticals submits NDA for dental anesthetic reversal agent

Experimental flu vaccine produced using insect cells shows promise

Experimental flu vaccine produced using insect cells shows promise

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.